Evidence map›Paper›PMID 33712545›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2021

Protein sequence design by conformational landscape optimization.

Christoffer Norn, Basile I M Wicky, David Juergens, Sirui Liu, David Kim, Doug Tischer, Brian Koepnick, Ivan Anishchenko, Foldit Players, David Baker and 1 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed
10.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 147 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Ensemble-conditioned protein sequence design with Caliby.bioRxiv : the preprint server for biology · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Designed miniproteins potently inhibit and protect against MERS-CoV.bioRxiv : the preprint server for biology · 2024
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Christoffer NornDepartment of Biochemistry, University of Washington, Seattle, WA 98105.ORCID 0000-0002-1450-4651
Basile I M WickyDepartment of Biochemistry, University of Washington, Seattle, WA 98105.ORCID 0000-0002-2501-7875
David JuergensDepartment of Biochemistry, University of Washington, Seattle, WA 98105.
Sirui LiuFaculty of Arts and Sciences, Division of Science, Harvard University, Cambridge, MA 02138.
David KimDepartment of Biochemistry, University of Washington, Seattle, WA 98105.
Doug TischerDepartment of Biochemistry, University of Washington, Seattle, WA 98105.
Brian KoepnickDepartment of Biochemistry, University of Washington, Seattle, WA 98105.
Ivan AnishchenkoDepartment of Biochemistry, University of Washington, Seattle, WA 98105.ORCID 0000-0003-3645-2044
Foldit Players
David BakerDepartment of Biochemistry, University of Washington, Seattle, WA 98105; dabaker@uw.edu so@fas.harvard.edu.ORCID 0000-0001-7896-6217
Sergey OvchinnikovFaculty of Arts and Sciences, Division of Science, Harvard University, Cambridge, MA 02138; dabaker@uw.edu so@fas.harvard.edu.ORCID 0000-0003-2774-2744
University of Washington · USHarvard University · USHoward Hughes Medical Institute · US

Funding

Exploring the unknown protein universe using evolutionary informationDP5OD026389 · OD · HARVARD UNIVERSITY · PI OVCHINNIKOV, SERGEY L. · 2018 to 2022
$2.0M
Howard Hughes Medical InstituteNIAID NIH HHS HHSN272201700059CNIH HHS DP5 OD026389
6 · The paper itself

Abstract

The protein design problem is to identify an amino acid sequence that folds to a desired structure. Given Anfinsen's thermodynamic hypothesis of folding, this can be recast as finding an amino acid sequence for which the desired structure is the lowest energy state. As this calculation involves not only all possible amino acid sequences but also, all possible structures, most current approaches focus instead on the more tractable problem of finding the lowest-energy amino acid sequence for the desired structure, often checking by protein structure prediction in a second step that the desired structure is indeed the lowest-energy conformation for the designed sequence, and typically discarding a large fraction of designed sequences for which this is not the case. Here, we show that by backpropagating gradients through the transform-restrained Rosetta (trRosetta) structure prediction network from the desired structure to the input amino acid sequence, we can directly optimize over all possible amino acid sequences and all possible structures in a single calculation. We find that trRosetta calculations, which consider the full conformational landscape, can be more effective than Rosetta single-point energy estimations in predicting folding and stability of de novo designed proteins. We compare sequence design by conformational landscape optimization with the standard energy-based sequence design methodology in Rosetta and show that the former can result in energy landscapes with fewer alternative energy minima. We show further that more funneled energy landscapes can be designed by combining the strengths of the two approaches: the low-resolution trRosetta model serves to disfavor alternative states, and the high-resolution Rosetta model serves to create a deep energy minimum at the design target structure.

Indexed as

Neural Networks, ComputerModels, MolecularProtein ConformationProtein FoldingProteinsThermodynamicsProteinsenergy landscapemachine learningprotein designsequence optimizationstability prediction

Identifiers

PMID33712545
PMCPMC7980421
OpenAlexW3134186384

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.